Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies
- PMID: 19861541
- DOI: 10.1158/0008-5472.CAN-09-0551
Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies
Abstract
Disruption of circadian rhythms, daily oscillations in biological processes that are regulated by an endogenous clock, has been linked to tumorigenesis. Normal and malignant tissues often show asynchronies in cell proliferation and metabolic rhythms. Cancer chronotherapy takes biological time into account to improve the therapy. However, alterations of the circadian clock machinery genes have rarely been reported in human cancer. Herein, we show that the BMAL1 gene, a core component of the circadian clock, is transcriptionally silenced by promoter CpG island hypermethylation in hematologic malignancies, such as diffuse large B-cell lymphoma and acute lymphocytic and myeloid leukemias. We also describe how BMAL1 reintroduction in hypermethylated leukemia/lymphoma cells causes growth inhibition in colony assays and nude mice, whereas BMAL1 depletion by RNA interference in unmethylated cells enhances tumor growth. We also show that BMAL1 epigenetic inactivation impairs the characteristic circadian clock expression pattern of genes such as C-MYC, catalase, and p300 in association with a loss of BMAL1 occupancy in their respective promoters. Furthermore, the DNA hypermethylation-associated loss of BMAL1 also prevents the recruitment of its natural partner, the CLOCK protein, to their common targets, further enhancing the perturbed circadian rhythm of the malignant cells. These findings suggest that BMAL1 epigenetic inactivation contributes to the development of hematologic malignancies by disrupting the cellular circadian clock.
Similar articles
-
Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies.Cancer Res. 2008 Jun 1;68(11):4116-22. doi: 10.1158/0008-5472.CAN-08-0085. Cancer Res. 2008. PMID: 18519670
-
Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.J Clin Oncol. 2005 Jun 10;23(17):3940-7. doi: 10.1200/JCO.2005.11.650. Epub 2005 May 2. J Clin Oncol. 2005. PMID: 15867203
-
Synergistic regulation of the mouse orphan nuclear receptor SHP gene promoter by CLOCK-BMAL1 and LRH-1.Biochem Biophys Res Commun. 2007 Feb 23;353(4):895-901. doi: 10.1016/j.bbrc.2006.12.131. Epub 2006 Dec 26. Biochem Biophys Res Commun. 2007. PMID: 17204240
-
Epigenetic changes in solid and hematopoietic tumors.Semin Oncol. 2005 Oct;32(5):521-30. doi: 10.1053/j.seminoncol.2005.07.003. Semin Oncol. 2005. PMID: 16210093 Review.
-
Gene silencing by DNA methylation in haematological malignancies.Br J Haematol. 2007 Jul;138(1):3-11. doi: 10.1111/j.1365-2141.2007.06604.x. Epub 2007 May 9. Br J Haematol. 2007. PMID: 17489980 Review.
Cited by
-
The role of circadian clock in regulating cell functions: implications for diseases.MedComm (2020). 2024 Mar 11;5(3):e504. doi: 10.1002/mco2.504. eCollection 2024 Mar. MedComm (2020). 2024. PMID: 38469551 Free PMC article. Review.
-
Traumatic brain injury-induced disruption of the circadian clock.J Mol Med (Berl). 2024 Mar;102(3):403-414. doi: 10.1007/s00109-024-02416-w. Epub 2024 Jan 29. J Mol Med (Berl). 2024. PMID: 38285094 Free PMC article.
-
The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer.Front Oncol. 2023 Nov 27;13:1295267. doi: 10.3389/fonc.2023.1295267. eCollection 2023. Front Oncol. 2023. PMID: 38090501 Free PMC article. Review.
-
The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia.J Exp Clin Cancer Res. 2023 Aug 24;42(1):218. doi: 10.1186/s13046-023-02799-7. J Exp Clin Cancer Res. 2023. PMID: 37620852 Free PMC article.
-
Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology.Nat Rev Gastroenterol Hepatol. 2023 Nov;20(11):695-707. doi: 10.1038/s41575-023-00792-1. Epub 2023 Jun 8. Nat Rev Gastroenterol Hepatol. 2023. PMID: 37291279 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous